Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hartley

Showing results (421-430 of 451) with videos related to

Pageof 46
Sort By:
Nature Genetics|March 10, 2001
Open-reading-frame sequence tags (OSTs) support the existence of at least 17,300 genes in C. elegansJ Reboul, P Vaglio, N Tzellas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Proteomic profiling identifies afamin as a potential biomarker for ovarian cancerDavid Jackson, Rachel A Craven, Richard C Hutson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 29, 2023
Characterizing the emergence of amyloid and tau burden in Down syndromeMatthew D Zammit, Tobey J Betthauser, Andrew K McVea, et al.
Sleep Advances : a Journal of the Sleep Research Society|June 7, 2022
Obstructive sleep apnea, cerebrovascular disease, and amyloid in older adults with Down syndrome across the Alzheimer's continuumPatrick Lao, Molly E Zimmerman, Sigan L Hartley, et al.
Journal of Alzheimer'S Disease : JAD|December 20, 2017
Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-β Burden in Down SyndromePatrick J Lao, Ben L Handen, Tobey J Betthauser, et al.
Journal of Medical Genetics|August 29, 2024
Genetic findings in people with schwannomas who do not meet clinical diagnostic criteria for <i>NF2</i>-related schwannomatosisMiriam J Smith, Cristina Perez-Becerril, Mwee van der Meer, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 21, 2026
The impact of congenital heart disease on the timing of Alzheimer's disease in Down syndromeJulianne G Clina, Brian C Helsel, Sigan L Hartley, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 19, 2023
Alzheimer's polygenic risk scores are associated with cognitive phenotypes in Down syndromePriyanka Gorijala, M Muaaz Aslam, Lam-Ha T Dang, et al.
The Lancet. Neurology|June 20, 2025
Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers: a longitudinal cohort studyShorena Janelidze, Lyduine E Collij, Niklas Mattsson-Carlgren, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 13, 2017
Longitudinal changes in amyloid positron emission tomography and volumetric magnetic resonance imaging in the nondemented Down syndrome populationPatrick J Lao, Ben L Handen, Tobey J Betthauser, et al.
Pageof 46

Showing results (421-430 of 451) with videos related to

Sort By:
Pageof 46
Nature Genetics|March 10, 2001
Open-reading-frame sequence tags (OSTs) support the existence of at least 17,300 genes in C. elegansJ Reboul, P Vaglio, N Tzellas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Proteomic profiling identifies afamin as a potential biomarker for ovarian cancerDavid Jackson, Rachel A Craven, Richard C Hutson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 29, 2023
Characterizing the emergence of amyloid and tau burden in Down syndromeMatthew D Zammit, Tobey J Betthauser, Andrew K McVea, et al.
Sleep Advances : a Journal of the Sleep Research Society|June 7, 2022
Obstructive sleep apnea, cerebrovascular disease, and amyloid in older adults with Down syndrome across the Alzheimer's continuumPatrick Lao, Molly E Zimmerman, Sigan L Hartley, et al.
Journal of Alzheimer'S Disease : JAD|December 20, 2017
Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-β Burden in Down SyndromePatrick J Lao, Ben L Handen, Tobey J Betthauser, et al.
Journal of Medical Genetics|August 29, 2024
Genetic findings in people with schwannomas who do not meet clinical diagnostic criteria for <i>NF2</i>-related schwannomatosisMiriam J Smith, Cristina Perez-Becerril, Mwee van der Meer, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 21, 2026
The impact of congenital heart disease on the timing of Alzheimer's disease in Down syndromeJulianne G Clina, Brian C Helsel, Sigan L Hartley, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 19, 2023
Alzheimer's polygenic risk scores are associated with cognitive phenotypes in Down syndromePriyanka Gorijala, M Muaaz Aslam, Lam-Ha T Dang, et al.
The Lancet. Neurology|June 20, 2025
Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers: a longitudinal cohort studyShorena Janelidze, Lyduine E Collij, Niklas Mattsson-Carlgren, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 13, 2017
Longitudinal changes in amyloid positron emission tomography and volumetric magnetic resonance imaging in the nondemented Down syndrome populationPatrick J Lao, Ben L Handen, Tobey J Betthauser, et al.
Pageof 46